Effective use of pre-exposure prophylaxis (PrEP) Among stimulant users with multiple condomless sex partners: a longitudinal study of men who have sex with men in Los Angeles

References

• Anderson, P. L., Liu, A. Y., Castillo-Mancilla, J. R., Gardner, E. M., Seifert, S. M., McHugh, C., … MaWhinney, S. (2018). Intracellular tenofovir-diphosphate and emtricitabine-triphosphate in dried blood spots following directly observed therapy. Antimicrobial Agents and Chemotherapy, 62(1), 2587. doi: 10.1128/AAC.01710-17
   Web of Science ®Google Scholar
• Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., … Celum, C. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367(5), 399–410. doi: 10.1056/NEJMoa1108524
   PubMed Web of Science ®Google Scholar
• Castel, A. D., Feaster, D. J., Tang, W., Willis, S., Jordan, H., Villamizar, K., … Metsch, L. R. (2015). Understanding HIV care provider attitudes regarding intentions to prescribe PrEP. Journal of Acquired Immune Deficiency Syndromes, 70(5), 520–528. doi: 10.1097/QAI.0000000000000780
   PubMed Web of Science ®Google Scholar
• Closson, E. F., Mitty, J. A., Malone, J., Mayer, K. H., & Mimiaga, M. J. (2017). Exploring strategies for PrEP adherence and dosing preferences in the context of sexualized recreational drug use among MSM: A qualitative study. AIDS Care, 1(4), 1–8. doi: 10.1080/09540121.2017.1360992
   Google Scholar
• Drumright, L. N., Patterson, T. L., & Strathdee, S. A. (2006). Club drugs as causal risk Factors for HIV acquisition among men who have sex with men: A review. Substance Use & Misuse, 41(10-12), 1551–1601. doi: 10.1080/10826080600847894
   PubMed Web of Science ®Google Scholar
• Grant, R. M., Anderson, P. L., McMahan, V., Liu, A., Amico, K. R., Mehrotra, M., … Glidden, D. V. (2014). Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: A cohort study. The Lancet Infectious Diseases, 14(9), 820–829. doi: 10.1016/S1473-3099(14)70847-3
   PubMed Web of Science ®Google Scholar
• Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., … Glidden, D. V. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27), 2587–2599. doi: 10.1056/NEJMoa1011205
   PubMed Web of Science ®Google Scholar
• Haberer, J. E., Bangsberg, D. R., Baeten, J. M., Curran, K., Koechlin, F., Amico, K. R., … O’Reilly, K. (2015). Defining success with HIV pre-exposure prophylaxis: A prevention-effective adherence paradigm. Aids, 29(11), 1277–1285. doi: 10.1097/QAD.0000000000000647
   PubMed Web of Science ®Google Scholar
• Haberer, J. E., Kidoguchi, L., Heffron, R., Mugo, N., Bukusi, E., Katabira, E., … Baeten, J. M. (2017). Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: A prospective analysis of prevention-effective adherence. Journal of the International AIDS Society, 20(1), 21842. doi: 10.7448/IAS.20.1.21842
   PubMedGoogle Scholar
• Hoagland, B., Moreira, R. I., De Boni, R. B., Kallas, E. G., Madruga, J. V., Vasconcelos, R., … Grinsztejn, B. (2017). High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV infection: The PrEP Brasil demonstration project. Journal of the International AIDS Society, 20(1), 21472. doi: 10.7448/IAS.20.1.21472
   PubMedGoogle Scholar
• Hoenigl, M., Jain, S., Moore, D., Collins, D., Sun, X., Anderson, P. L., … Morris, S. (2018). Substance use and adherence to HIV preexposure prophylaxis for men who have sex with men. Emerging Infectious Diseases, 24(12). doi: 10.3201/eid2412.180400
   Web of Science ®Google Scholar
• Hojilla, J. C., Vlahov, D., Glidden, D. V., Amico, K. R., Mehrotra, M., Hance, R., … Carrico, A. W. (2018). Skating on thin ice: Stimulant use and sub-optimal adherence to HIV pre-exposure prophylaxis. Journal of the International AIDS Society, 21(3), e25103. doi: 10.1002/jia2.25103
   PubMed Web of Science ®Google Scholar
• Hosek, S. G., Rudy, B., Landovitz, R., Kapogiannis, B., Siberry, G., Rutledge, B., … Wilson, C. M. (2017). An HIV preexposure prophylaxis demonstration project and safety study for Young MSM. Journal of Acquired Immune Deficiency Syndromes, 74(1), 21–29. doi: 10.1097/QAI.0000000000001179
   PubMed Web of Science ®Google Scholar
• Kelley, C. F., Kahle, E., Siegler, A., Sanchez, T., del Rio, C., Sullivan, P. S., & Rosenberg, E. S. (2015). Applying a PrEP continuum of care for men who have sex with men in Atlanta, Georgia. Clinical Infectious Diseases, 61(10), 1590–1597. doi: 10.1093/cid/civ664
   PubMed Web of Science ®Google Scholar
• Koblin, B. A., Husnik, M. J., Colfax, G., Huang, Y., Madison, M., Mayer, K., … Buchbinder, S., (2006). Risk factors for HIV infection among men who have sex with men. Aids (london, England), 20(5), 731–739. doi: 10.1097/01.aids.0000216374.61442.55
   PubMed Web of Science ®Google Scholar
• Landovitz, R. J., Beymer, M., Kofron, R., Amico, K. R., Psaros, C., Bushman, L., … Wohl, A. R. (2017). Plasma tenofovir levels to support adherence to TDF/FTC Preexposure prophylaxis for HIV prevention in MSM in Los Angeles, California. Journal of Acquired Immune Deficiency Syndromes, 76(5), 501–511. doi: 10.1097/QAI.0000000000001538
   PubMed Web of Science ®Google Scholar
• Lim, S. H., Ostrow, D., Stall, R., Chmiel, J., Herrick, A., Shoptaw, S., … Plankey, M. (2012). Changes in stimulant drug use over time in the MACS: Evidence for resilience against stimulant drug use among men who have sex with men. AIDS and Behavior, 16(1), 151–158. doi: 10.1007/s10461-010-9866-x
   PubMed Web of Science ®Google Scholar
• Liu, A. Y., Cohen, S. E., Vittinghoff, E., Anderson, P. L., Doblecki-Lewis, S., Bacon, O., … Kolber, M. A. (2016). Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services. JAMA Internal Medicine, 176(1), 75. doi: 10.1001/jamainternmed.2015.4683
   PubMed Web of Science ®Google Scholar
• Marrazzo, J. M., Ramjee, G., Richardson, B. A., Gomez, K., Mgodi, N., Nair, G., … Chirenje, Z. M. (2015). Tenofovir-based preexposure prophylaxis for HIV infection among African women. New England Journal of Medicine, 372(6), 509–518. doi: 10.1056/NEJMoa1402269
   PubMed Web of Science ®Google Scholar
• Molina, J.-M., Capitant, C., Spire, B., Pialoux, G., Cotte, L., Charreau, I., … Delfraissy, J.-F. (2015). On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. New England Journal of Medicine, 373(23), 2237–2246. doi: 10.1056/NEJMoa1506273
   PubMed Web of Science ®Google Scholar
• NIDA. (2012, March 1). Resource guide: Screening for drug use in general medical settings. Retrieved from https://www.who.int/substance_abuse/activities/assist_v3_english.pdf
   Google Scholar
• Nunn, A. S., Brinkley-rubinstein, L., Oldenburg, C. E., Mayer, K. H., Mimiaga, M., Patel, R., & Chan, P. A. (2017). Defining the Hiv pre-exposure prophylaxis care continuum. Aids, 31(5), 731–734. doi: 10.1097/QAD.0000000000001385
   PubMed Web of Science ®Google Scholar
• Oldenburg, C. E., Mitty, J. A., Biello, K. B., Closson, E. F., Safren, S. A., Mayer, K. H., & Mimiaga, M. J. (2016). Differences in attitudes about HIV pre-exposure prophylaxis use among stimulant versus alcohol using men who have sex with men. AIDS and Behavior, 20(7), 1451–1460. doi: 10.1007/s10461-015-1226-4
   PubMed Web of Science ®Google Scholar
• Storholm, E. D., Volk, J. E., Marcus, J. L., Silverberg, M. J., & Satre, D. D. (2017). Risk perception, sexual behaviors, and PrEP adherence among substance-using men who have sex with men: A qualitative study. Prevention Science, 18(6), 737–747. doi: 10.1007/s11121-017-0799-8
   PubMed Web of Science ®Google Scholar
• Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., … Brooks, J. T. (2012). Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. New England Journal of Medicine, 367(5), 423–434. doi: 10.1056/NEJMoa1110711
   PubMed Web of Science ®Google Scholar
• Van Damme, L., Corneli, A., Ahmed, K., Agot, K., Lombaard, J., Kapiga, S., … Taylor, D. (2012). Preexposure prophylaxis for HIV infection among African women. New England Journal of Medicine, 367(5), 411–422. doi: 10.1056/NEJMoa1202614
   PubMed Web of Science ®Google Scholar